Unlock stock picks and a broker-level newsfeed that powers Wall Street.
BSE - Delayed Quote INR

Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)

Compare
1,696.95
-38.50
(-2.22%)
At close: 3:55:48 PM GMT+5:30
Loading Chart for SUNPHARMA.BO
  • Previous Close 1,735.45
  • Open 1,727.15
  • Bid 1,698.30 x --
  • Ask 1,701.20 x --
  • Day's Range 1,681.25 - 1,732.90
  • 52 Week Range 1,376.75 - 1,960.20
  • Volume 194,187
  • Avg. Volume 51,563
  • Market Cap (intraday) 4.072T
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 35.56
  • EPS (TTM) 47.72
  • Earnings Date May 20, 2025 - May 24, 2025
  • Forward Dividend & Yield 15.50 (0.89%)
  • Ex-Dividend Date Feb 6, 2025
  • 1y Target Est 2,051.84

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.

www.sunpharma.com

43,000

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUNPHARMA.BO

View More

Performance Overview: SUNPHARMA.BO

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUNPHARMA.BO
9.41%
S&P BSE SENSEX (^BSESN)
2.71%

1-Year Return

SUNPHARMA.BO
5.01%
S&P BSE SENSEX (^BSESN)
2.72%

3-Year Return

SUNPHARMA.BO
91.69%
S&P BSE SENSEX (^BSESN)
28.25%

5-Year Return

SUNPHARMA.BO
417.57%
S&P BSE SENSEX (^BSESN)
168.97%

Compare To: SUNPHARMA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUNPHARMA.BO

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    4.16T

  • Enterprise Value

    3.98T

  • Trailing P/E

    36.38

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.15

  • Price/Book (mrq)

    6.02

  • Enterprise Value/Revenue

    7.80

  • Enterprise Value/EBITDA

    24.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.16%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    516.02B

  • Net Income Avi to Common (ttm)

    114.34B

  • Diluted EPS (ttm)

    47.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    201.22B

  • Total Debt/Equity (mrq)

    3.71%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SUNPHARMA.BO

View More

Company Insights: SUNPHARMA.BO

Research Reports: SUNPHARMA.BO

View More

People Also Watch